Back to top

Company Overview

Headquarter Microsynth AG

Founded in 1989 and headquartered in Switzerland, Microsynth is a leading European company in the synthesis and analysis of nucleic acids. Our business is organized into three core areas:

  1. DNA/RNA Synthesis
  2. DNA/RNA Analysis and Sequencing
  3. Contract Research and Outsourcing Services

With over three decades of experience, we are committed to providing high-quality, reliable, and timely products and services—supported by excellent customer service and competitive pricing.



Microsynth operates subsidiaries in:

  • Germany – Microsynth Seqlab GmbH
  • France – Microsynth France SAS
  • Austria – Microsynth Austria GmbH
  • Switzerland – Ecogenics GmbH

The company currently employs 150 professionals across all locations.

All Microsynth branches are ISO 9001:2015 certified. In addition, our sites in Switzerland and Austria hold ISO/IEC 17025:2017 accreditation for selected Sanger sequencing, fragment length analysis, and NGS services. Microsynth AG is also GMP-compliant for quality control of medicinal products (certified by Swissmedic) and certified according to EN ISO 13485:2016 for the production and distribution of nucleic acids for medical use.

 

Company Mission

 

We’re truly proud to be a pillar of scientific progress in pharma, biotech, and medicine. Since being founded in 1989, we’ve been incredibly passionate about the synthesis and analysis of nucleic acids - whether it is for basic research, diagnostic, or therapeutic applications. We act quickly and we’re easy to do business with, and we always show respect for the environment in everything we do.

History and Introduction

 

Microsynth was founded in 1989 by Dr. Tobias Schmidheini as a spin-off of ETH Zurich. When Dr. Schmidheini started producing DNA oligonucleotides on behalf of Swiss academic institutes, he was one of the pioneers in this field. We now offer our numerous customers a broad spectrum of high-quality DNA/RNA oligonucleotides for research, drug development and molecular diagnostics.

In 1992, Microsynth decided to enter the field of DNA sequencing. Thirty years on, we are very well positioned in this field and can offer our customers both traditional Sanger sequencing services as well as state-of-the- art next generation sequencing services. And through establishing additional Sanger sequencing laboratories in Austria (Microsynth Austria GmbH in 2012), Germany (Microsynth Seqlab GmbH in 2013) and France (Microsynth France SAS in 2021) Microsynth has secured better access to key European markets. In the last two decades, sequencing has been complemented by various other specialized DNA/RNA-related areas such as nucleic acid isolation, PCR & qPCR & digital PCR, genotyping, and bioinformatics. Following the acquisition of Ecogenics GmbH (which specialized in microsatellite marker development and related genotyping services) in 2011, we were able to expand our methodological repertoire and gain access to new customer segments (e.g., ecologists, breeders, botanists, and zoologists).
The third and most recent department that Microsynth has created (which is known as Contract Research/Outsourcing) combines the company’s state-of-the-art portfolio in nucleic acid synthesis, sequencing, and analysis to establish tailor-made analysis pipelines for customer projects. Following the successful execution of various projects with customers in the clinical or regulated environment in the recent past, decisive regulatory and project-related competencies have been developed. Consequently, Microsynth is nowadays a proven CRO offering GLP/GMP-compliant assay development, validation, and sampling to support the development and production of drugs worldwide.

Company History Microsynth

Our Brand Promise


As a pioneer in our field, we have gained extensive critical expertise and experience related to DNA/RNA services since our incorporation in 1989. This expertise is our most valuable asset, and we attach great importance to continuously enhancing our expertise through our commitment to technical competence, diligence and reliability. For more than three decades, our objective has been to serve our customers by delivering products and services of the highest quality, on time, and with an outstanding service – and all this at competitive prices. Last but not least, we are committed to sustainable development and to the protection of the natural resources of our planet.

 

Brand Promise Microsynth

Management

Microsynth AG

Our two Co-CEOs, Christof Wunderlin (right) and Dr. Markus Schmid (left). Christof Wunderlin is responsible for Sales, Finance and Human Resources, while Dr. Markus Schmid is responsible for Operations and Quality Systems. The members of the management team together determine Microsynth’s strategy and have committed themselves to drive forward the internationalization and further growth of the company, while always acting in a sustainable and socially responsible manner.

Management Microsynth

Left: Markus Schmid / Right: Christof Wunderlin

Microsynth Seqlab GmbH

Dr. Aaron M. Nuss has joined Microsynth Seqlab in the beginning of 2017 to run the sequencing lab and operational activities of the company.

Aaron M. Nuss

Microsynth Austria GmbH

Bernhard Binishofer has been with Microsynth Austria since its founding in 2012, where he heads the sequencing laboratory.

Mag. Bernhard Binishofer

Microsynth France SAS

Mr Benjamin Marteaux is running the sequencing lab and operational activities of Microsynth France. He is the follower of Ms Farida Mebarki.

Benjamin Marteaux

Video Portrait